Evidence map›Paper›PMID 31145752›Full record

ArticlePloS one2019

Developing a dynamic HIV transmission model for 6 U.S. cities: An evidence synthesis.

Emanuel Krebs, Benjamin Enns, Linwei Wang, Xiao Zang, Dimitra Panagiotoglou, Carlos Del Rio, Julia Dombrowski, Daniel J Feaster, Matthew Golden, Reuben Granich and 7 more

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The healthier healthcare management models for COVID-19.Journal of infection and public health · 2021
    Review
  15. Article
  16. Review
  17. "Ending the Epidemic" Will Not Happen Without Addressing Racial/Ethnic Disparities in the United States Human Immunodeficiency Virus Epidemic.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  18. Prioritizing Additional Data Collection to Reduce Decision Uncertainty in the HIV/AIDS Response in 6 US Cities: A Value of Information Analysis.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2020
    Article
  19. Article
  20. Dissemination Science to Advance the Use of Simulation Modeling: Our Obligation Moving Forward.Medical decision making : an international journal of the Society for Medical Decision Making · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Emanuel KrebsHealth Economic Research Unit at the British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.ORCID 0000-0002-6590-8728
Benjamin EnnsHealth Economic Research Unit at the British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.
Linwei WangHealth Economic Research Unit at the British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.
Xiao ZangHealth Economic Research Unit at the British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.
Dimitra PanagiotoglouHealth Economic Research Unit at the British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.
Carlos Del RioHubert Department of Global Health, Emory Center for AIDS Research, Rollins School of Public Health, Emory University, Atlanta, GA, United States of America.
Julia DombrowskiDepartment of Medicine, Division of Allergy & Infectious Disease, adjunct in Epidemiology, University of Washington, Seattle, WA, United States of America.
Daniel J FeasterCenter for Family Studies, Department of Epidemiology and Public Health, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, United States of America.
Matthew GoldenDepartment of Medicine, Division of Allergy & Infectious Disease, adjunct in Epidemiology, University of Washington, Seattle, WA, United States of America.
Reuben GranichInternational Association of Providers of AIDS Care, Washington, DC, United States of America.
Brandon MarshallDepartment of Epidemiology, Brown School of Public Health, Providence, RI, United States of America.ORCID 0000-0002-0134-7052
Shruti H MehtaBloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States of America.
Lisa MetschDepartment of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York, NY, United States of America.
Bruce R SchackmanDepartment of Healthcare Policy and Research, Weill Cornell Medical College, New York, NY, United States of America.
Steffanie A StrathdeeSchool of Medicine, University of California San Diego, La Jolla, CA, United States of America.
Bohdan NosykHealth Economic Research Unit at the British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.ORCID 0000-0003-2513-3718
localized HIV modeling study group

Funding

The AIDS Linked to the Intravenous Experience (ALIVE) StudyU01DA036297 · NIDA · JOHNS HOPKINS UNIVERSITY · PI Gregory D Kirk, Shruti H Mehta · 2014 to 2026
$28.9M
Utilization of health services after engagement with opioid use disorder (OUD) treatment provider by individuals with and without post-traumatic stress disorderP30DA040500 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI ZACHARY Franklin MEISEL · 2015 to 2026
$20.7M
INCIDENCE OF HIV INFECTIONS IN A COHORT OF IV DRUG USERSR01DA012568 · NIDA · JOHNS HOPKINS UNIVERSITY · PI MEHTA, SHRUTI H · 1999 to 2017
$15.5M
Impact of Drug Policy Reform on the HIV Risk Environment among IDUs in TijuanaR37DA019829 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STRATHDEE, STEFFANIE A. · 2010 to 2019
$6.7M
Localized economic modeling to support implementation of the Ending the HIV Epidemic initiativeR01DA041747 · NIDA · SIMON FRASER UNIVERSITY · PI NOSYK, BOHDAN · 2016 to 2025
$5.5M
INCIDENCE OF HIV INFECTION IN A COHORT OF IV DRUG USERSR56DA012568 · NIDA · JOHNS HOPKINS UNIVERSITY · PI MEHTA, SHRUTI H · 2013 to 2013
$833k
NIDA NIH HHS P30 DA040500NIDA NIH HHS R01 DA012568NIDA NIH HHS R01 DA041747NIDA NIH HHS R37 DA019829NIDA NIH HHS R56 DA012568NIDA NIH HHS U01 DA036297
6 · The paper itself

Abstract

backgroundDynamic HIV transmission models can provide evidence-based guidance on optimal combination implementation strategies to treat and prevent HIV/AIDS. However, these models can be extremely data intensive, and the availability of good-quality data characterizing regional microepidemics varies substantially within and across countries. We aim to provide a comprehensive and transparent description of an evidence synthesis process and reporting framework employed to populate and calibrate a dynamic, compartmental HIV transmission model for six US cities.

methodsWe executed a mixed-method evidence synthesis strategy to populate model parameters in six categories: (i) initial HIV-negative and HIV-infected populations; (ii) parameters used to calculate the probability of HIV transmission; (iii) screening, diagnosis, treatment and HIV disease progression; (iv) HIV prevention programs; (v) the costs of medical care; and (vi) health utility weights for each stage of HIV disease progression. We identified parameters that required city-specific data and stratification by gender, risk group and race/ethnicity a priori and sought out databases for primary analysis to augment our evidence synthesis. We ranked the quality of each parameter using context- and domain-specific criteria and verified sources and assumptions with our scientific advisory committee.

findingsTo inform the 1,667 parameters needed to populate our model, we synthesized evidence from 59 peer-reviewed publications and 24 public health and surveillance reports and executed primary analyses using 11 data sets. Of these 1,667 parameters, 1,517 (91%) were city-specific and 150 (9%) were common for all cities. Notably, 1,074 (64%), 201 (12%) and 312 (19%) parameters corresponded to categories (i), (ii) and (iii), respectively. Parameters ranked as best- to moderate-quality evidence comprised 39% of the common parameters and ranged from 56%-60% across cities for the city-specific parameters. We identified variation in parameter values across cities as well as within cities across risk and race/ethnic groups.

conclusionsBetter integration of modelling in decision making can be achieved by systematically reporting on the evidence synthesis process that is used to populate models, and by explicitly assessing the quality of data entered into the model. The effective communication of this process can help prioritize data collection of the most informative components of local HIV prevention and care services in order to reduce decision uncertainty and strengthen model conclusions.

Indexed as

Antiretroviral Therapy, Highly ActiveAcquired Immunodeficiency SyndromeCitiesEpidemiologic StudiesHIVHIV InfectionsHumansPre-Exposure ProphylaxisRisk FactorsSexual and Gender MinoritiesUnited States

Identifiers

PMID31145752
PMCPMC6542533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.